INS and Insulin resistance: The intervention increased folate as expected, modestly reduced homocysteine and two markers of insulin resistance, free fatty acids and triglycerides, but did not affect insulin, colonic inflammation, as assessed by faecal calprotectin, or generalised inflammation, as assessed by C-reactive protein.